| Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy S Palmer, F Maldarelli, A Wiegand, B Bernstein, GJ Hanna, SC Brun, ... Proceedings of the National Academy of Sciences 105 (10), 3879-3884, 2008 | 779 | 2008 |
| Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Q Yu, R König, S Pillai, K Chiles, M Kearney, S Palmer, D Richman, ... Nature structural & molecular biology 11 (5), 435-442, 2004 | 748 | 2004 |
| New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma S Palmer, AP Wiegand, F Maldarelli, H Bazmi, JAM Mican, M Polis, ... Journal of clinical microbiology 41 (10), 4531-4536, 2003 | 739 | 2003 |
| Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction DE Kaufmann, DG Kavanagh, F Pereyra, JJ Zaunders, EW Mackey, ... Nature immunology 8 (11), 1246-1254, 2007 | 715 | 2007 |
| Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical … TA Rasmussen, M Tolstrup, CR Brinkmann, R Olesen, C Erikstrup, ... The lancet HIV 1 (1), e13-e21, 2014 | 691 | 2014 |
| Depletion of latent HIV-1 infection in vivo: a proof-of-concept study G Lehrman, IB Hogue, S Palmer, C Jennings, CA Spina, A Wiegand, ... The Lancet 366 (9485), 549-555, 2005 | 691 | 2005 |
| Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies S Eriksson, EH Graf, V Dahl, MC Strain, SA Yukl, ES Lysenko, RJ Bosch, ... PLoS pathogens 9 (2), e1003174, 2013 | 683 | 2013 |
| Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control SA Migueles, CM Osborne, C Royce, AA Compton, RP Joshi, KA Weeks, ... Immunity 29 (6), 1009-1021, 2008 | 671 | 2008 |
| HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ... Nature medicine 16 (4), 460-465, 2010 | 660 | 2010 |
| Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 614 | 2012 |
| Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis S Palmer, M Kearney, F Maldarelli, EK Halvas, CJ Bixby, H Bazmi, D Rock, ... Journal of clinical microbiology 43 (1), 406-413, 2005 | 610 | 2005 |
| Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ... PLoS pathogens 10 (11), e1004473, 2014 | 570 | 2014 |
| Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy JB Dinoso, SY Kim, AM Wiegand, SE Palmer, SJ Gange, L Cranmer, ... Proceedings of the National Academy of Sciences 106 (23), 9403-9408, 2009 | 550 | 2009 |
| International AIDS Society global scientific strategy: towards an HIV cure 2016 SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ... Nature medicine 22 (8), 839-850, 2016 | 494 | 2016 |
| ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia F Maldarelli, S Palmer, MS King, A Wiegand, MA Polis, JA Mican, ... PLoS pathogens 3 (4), e46, 2007 | 401 | 2007 |
| Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants B Hiener, BA Horsburgh, JS Eden, K Barton, TE Schlub, E Lee, ... Cell reports 21 (3), 813-822, 2017 | 383 | 2017 |
| The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial RT Gandhi, L Zheng, RJ Bosch, ES Chan, DM Margolis, S Read, ... PLoS medicine 7 (8), e1000321, 2010 | 366 | 2010 |
| Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ... PLoS pathogens 9 (5), e1003347, 2013 | 361 | 2013 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 344 | 2022 |
| The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time L Josefsson, S Von Stockenstrom, NR Faria, E Sinclair, P Bacchetti, ... Proceedings of the National Academy of Sciences 110 (51), E4987-E4996, 2013 | 326 | 2013 |
